MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6402-382-394$20.00
Mol Pharmacol 64:382-394, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Efferth, T.
Right arrow Articles by Funk, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Efferth, T.
Right arrow Articles by Funk, J. O.

Molecular Modes of Action of Artesunate in Tumor Cell Lines

Thomas Efferth, Axel Sauerbrey, Armin Olbrich, Erich Gebhart, Pia Rauch1, H. Oliver Weber2, Jan G. Hengstler, Marc-Eric Halatsch, Manfred Volm, Kenneth D. Tew, Douglas D. Ross, and Jens Oliver Funk

Center for Molecular Biology of the University of Heidelberg (ZMBH), Heidelberg, Germany (T.E.); Department of Pediatrics, University of Jena, Jena, Germany (A.S.); Hospital Pharmacy, University of Aachen, Aachen, Germany A.O.); Institute of Human Genetics (E.G.) and Laboratory of Molecular Tumor Biology, Department for Dermatology (P.R., H.O.W.), University of Erlangen-Nuremberg, Erlangen, Germany; Institute of Toxicology, University of Mainz, Mainz, Germany (J.G.H.); Department of Neurosurgery, University of Göttingen, Göttingen, Germany (M.-E.H.); German Cancer Research Center, Heidelberg, Germany (M.V.); Department of Pharmacology, Fox Chase Center, Philadelphia, Pennsylvania (K.D.T.); University of Maryland Greenebaum Cancer Center, Department of Medicine, University of Maryland School of Medicine, and the Baltimore Veterans Affairs Medical Center, Baltimore, Maryland (D.D.R.); and Department for Oncology Research, Merck KGaA, Darmstadt, Germany (J.O.F.)

A profound cytotoxic action of the antimalarial, artesunate (ART), was identified against 55 cancer cell lines of the U.S. National Cancer Institute (NCI). The 50% inhibition concentrations (IC50 values) for ART correlated significantly to the cell doubling times (P = 0.00132) and the portion of cells in the G0/G1 (P = 0.02244) or S cell cycle phases (P = 0.03567). We selected mRNA expression data of 465 genes obtained by microarray hybridization from the NCI data base. These genes belong to different biological categories (drug resistance genes, DNA damage response and repair genes, oncogenes and tumor suppressor genes, apoptosis-regulating genes, proliferation-associated genes, and cytokines and cytokine-associated genes). The constitutive expression of 54 of 465 (=12%) genes correlated significantly to the IC50 values for ART. Hierarchical cluster analysis of these 12 genes allowed the differentiation of clusters with ART-sensitive or ART-resistant cell lines (P = 0.00017). For exemplary validation, cell lines transduced with 3 of the 12 genes were used to prove a causative relationship. The cDNAs for a deletion-mutated epidermal growth factor receptor (EGFR) and for {gamma}-glutamylcysteine synthetase increased resistance to ART. The conditional expression of the CDC25A gene using a tetracycline repressor expression vector increased sensitivity toward ART. Multidrug-resistant cells differentially expressing the MDR1, MRP1, or BCRP genes were not cross-resistant to ART. ART acts via p53-dependent and- independent pathways in isogenic p53+/+ p21WAF1/CIP1+/+, p53-/- p21WAF1/CIP1+/+, and p53+/+ p21WAF1/CIP1-/- colon carcinoma cells.


Received January 30, 2003; accepted April 28, 2003

Address correspondence to: Thomas Efferth, Center for Molecular Biology of the University of Heidelberg (ZMBH), Heidelberg, Germany. E-mail: thomas.efferth{at}web.de




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. C.H. Li, E. Lam, W. P. Roos, M. Z. Zdzienicka, B. Kaina, and T. Efferth
Artesunate Derived from Traditional Chinese Medicine Induces DNA Damage and Repair
Cancer Res., June 1, 2008; 68(11): 4347 - 4351.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Mookerjee, J. Mookerjee Basu, P. Dutta, S. Majumder, S. Bhattacharyya, J. Biswas, S. Pal, P. Mukherjee, S. Raha, R. N. Baral, et al.
Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis.
Clin. Cancer Res., July 15, 2006; 12(14): 4339 - 4349.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
C J Woodrow, R K Haynes, and S Krishna
Artemisinins
Postgrad. Med. J., February 1, 2005; 81(952): 71 - 78.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. S. Lazo, A. P. Ducruet, and R. P. Koldamova
Sleuthful Pharmacology
Mol. Pharmacol., August 1, 2003; 64(2): 199 - 201.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics